Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

Legend Biotech stock is trading steadily on Nasdaq, backed by recent quarterly revenue growth and a solid biotech pipeline that keeps the company on investors’ radar.

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the ...